Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function

Cancer Research

Volumn 69, Issue 1, 2009, Pages 219-226

  Cano, Carla E ^a,b   Gommeaux, Julien ^a,b   Pietri, Sylvia ^b   Culcasi, Marcel ^b   Garcia, Stéphane ^a,b   Seux, Mylène ^a,b   Barelier, Sarah ^a,b   Vasseur, Sophie ^a,b   Spoto, Rose P ^a,b   Pébusque, Marie Josèphe ^a,b   Dusetti, Nelson J ^a,b   Iovanna, Juan L ^a,b   Carrier, Alice ^a,b  

^a INSERM   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; NUCLEAR PROTEIN; PROTEIN BAX; PROTEIN P21; PROTEIN P53; PROTEIN SESN2; PROTEIN TAP73; PUMA PROTEIN; REACTIVE OXYGEN METABOLITE; SERINE; TUMOR PROTEIN 53 INDUCED NUCLEAR PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE; GENE OVEREXPRESSION; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL GROWTH PROCESSES; CELL LINE; FIBROBLASTS; HYDROGEN PEROXIDE; LYMPHOMA; MICE; MICE, KNOCKOUT; NUCLEAR PROTEINS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 58249113824     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-2320     Document Type: Article

References (26)

1. Murphy ME, Leu JI, George DL. p53 moves to mitochondria: a turn on the path to apoptosis. Cell Cycle 2004;3:836-9.
2. Moll UM, Wolff S, Speidel D, Deppert W. Transcription-independent pro-apoptotic functions of p53. Curr Opin Cell Biol 2005;17:631-6.
3. Sablina AA, Budanov AV, Ilyinskaya GV, Agapova LS, Kravchenko JE, Chumakov PM. The antioxidant function of the p53 tumor suppressor. Nat Med 2005;11:1306-13.
4. Budanov AV, Sablina AA, Feinstein E, Koonin EV, Chumakov PM. Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science 2004;304:596-600.
5. Macip S, Igarashi M, Berggren P, Yu J, Lee SW, Aaronson SA. Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol Cell Biol 2003;23:8576-85.
6. Liu Z, Lu H, Shi H, et al. PUMA overexpression induces reactive oxygen species generation and proteasome-mediated stathmin degradation in colorectal cancer cells. Cancer Res 2005;65:1647-54.
7. Carrier A, Nguyen C, Victorero G, et al. Differential gene expression in CD3ε- and RAG1-deficient thymuses: definition of a set of genes potentially involved in thymocyte maturation. Immunogenetics 1999;50:255-70.
8. Tomasini R, Samir AA, Vaccaro MI, et al. Molecular and functional characterization of the stress-induced protein (SIP) gene and its two transcripts generated by alternative splicing. SIP induced by stress and promotes cell death. J Biol Chem 2001;276:44185-92.
9. Okamura S, Arakawa H, Tanaka T, et al. p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis. Mol Cell 2001;8:85-94.
10. Tomasini R, Samir AA, Carrier A, et al. TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity. J Biol Chem 2003;278:37722-9.
11. 46 phosphorylation of p53 tumor suppressor in the apoptotic response to DNA damage. J Biol Chem 2006;281:5734-40.
12. Di Stefano V, Blandino G, Sacchi A, Soddu S, D'Orazi G. HIPK2 neutralizes MDM2 inhibition rescuing p53 transcriptional activity and apoptotic function. Oncogene 2004;23:5185-92.
13. Tomasini R, Seux M, Nowak J, et al. TP53INP1 is a novel p73 target gene that induces cell cycle arrest and cell death by modulating p73 transcriptional activity. Oncogene 2005;24:8093-104.
14. Hershko T, Chaussepied M, Oren M, Ginsberg D. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F. Cell Death Differ 2005;12:377-83.
15. Gommeaux J, Cano C, Garcia S, et al. Colitis and colitis-associated cancer are exacerbated in mice deficient for tumor protein 53-induced nuclear protein 1. Mol Cell Biol 2007;27:2215-28.
16. Jacks T, Remington L, Williams BO, et al. Tumor spectrum analysis in p53-mutant mice. Curr Biol 1994;4:1-7.
17. Harvey M, Sands AT, Weiss RS, et al. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 1993;8:2457-67.
18. Gironella M, Seux M, Xie MJ, et al. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc Natl Acad Sci U S A 2007;104:16170-5.
19. Halliwell B, Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 2004;142:231-55.
20. Culcasi M, Rockenbauer A, Mercier A, Clement JL, Pietri S. The line asymmetry of electron spin resonance spectra as a tool to determine the cis :trans ratio for spin-trapping adducts of chiral pyrrolines N-oxides: the mechanism of formation of hydroxyl radical adducts of EMPO, DEPMPO, and DIPPMPO in the ischemic-reperfused rat liver. Free Radic Biol Med 2006;40:1524-38.
21. Godar S, Ince TA, Bell GW, et al. Growth-inhibitory and tumor-suppressive functions of p53 depend on its repression of CD44 expression. Cell 2008;134:62-73.
22. 46 and is phosphorylated by HIPK2 in apoptosis. Cell Death Differ 2006;13:1994-7.
23. Fréjaville C, Karoui H, Tuccio B, et al. 5-(Diethoxyphosphoryl)-5- methyl-1-pyrroline N-oxide: a new efficient phosphorylated nitrone for the in vitro and in vivo spin trapping of oxygen-centered radicals. J Med Chem 1995;38:258-65.
24. Culcasi M, Muller A, Mercier A, et al. Early specific free radical-related cytotoxicity of gas phase cigarette smoke and its paradoxical temporary inhibition by tar: an electron paramagnetic resonance study with the spin trap DEPMPO. Chem Biol Interact 2006;164:215-31.
25. Hanna P, Chamulitrat W, Mason R. When are metal ion-dependent hydroxyl and alkoxyl radical adducts of 5,5-dimethyl-1-pyrroline N-oxide artifacts? Arch Biochem Biophys 1992;296:640-4.
26. Menon SG, Sarsour EH, Spitz DR, et al. Redox regulation of the G1 to S phase transition in the mouse embryo fibroblast cell cycle. Cancer Res 2003;63:2109-17.